Paclitaxel protein-bound 100MGS
Ended Awarded
- Contract number
- SPE2DR26FM09H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,027
Award facts
- Contract value 100% obligated
- $16,027.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Paclitaxel Protein-Bound 100mg pharmaceutical product. This firm fixed-price delivery order, valued at $16,027.18, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion deadline of November 7, 2025. This award was made without a set-aside designation, indicating competitive procurement through open competition.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent SPE2DX contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Paclitaxel Protein-Bound, a chemotherapy agent, reflects AmerisourceBergen's role in supporting the federal medical supply chain across multiple therapeutic domains and underscores the company's capacity to fulfill specialized pharmaceutical requirements for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM09H?
SPE2DR26FM09H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FM09H worth?
The government has obligated $16,027 on SPE2DR26FM09H.
Is contract SPE2DR26FM09H an order under another contract?
Yes. SPE2DR26FM09H is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM09H competed?
The extent of competition for SPE2DR26FM09H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award